A Diagnostic Study on Patients With Drug-induced Liver Injury

Status Not yet recruiting

Clinical Trial Summary

Clinical Trial Description

This study is a multi-center, prospective, non-interventional cohort study with an estimated enrollment of 600 patients with acute DILI. According to the inclusion and exclusion criteria, the RUCAM scale and/or expert evaluation, patients with a clinical diagnosis of acute DILI will be included in the study to establish a multi-center, prospective DILI cohort. Depending on the presence or absence of associated chronic liver disease, the patients will be divided into the basic DILI group with chronic liver disease and basic DILI group without chronic liver disease. All enrolled patients should complete at least six months of follow-up.

This research will propose a new or optimized DILI diagnostic scheme based on the analysis of the problems existing in the practice of RUCAM scale, the clinical characteristics and prognosis of DILI, the exploration of biomarkers, and all the comprehensive information of big data from Hepatox platform, and establish a big data-based diagnosis model or auxiliary diagnosis decision system. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04526548
Study type	Observational
Source	Drug Induced Liver Disease Study Group
Contact
Status	Not yet recruiting
Phase
Start date	October 2020
Completion date	October 2021

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03704792` - Validation of the Second Generation of the Controlled Attenuation Parameter (CAP) Using the MRI-PDFF as Reference	N/A
Terminated	`NCT02949375` - Trial to Examine the Effect of Two Doses of GRI-0621 in Patients With Chronic Liver Disease	Phase 2
Active, not recruiting	`NCT01205074` - ¹³C-Methacetin Breath Test (MBT) Methodology Study	Phase 2/Phase 3
Completed	`NCT00756171` - Colesevelam Versus Placebo in Cholestatic Pruritus	Phase 2/Phase 3
Completed	`NCT01195181` - Different PEG-interferon and Ribavirin Schedules for Chronic Hepatitis C in the Real Clinical Practice.	Phase 4
Completed	`NCT05044663` - Liver and Splenic Stiffness in Predicting Esophageal Varices Needing Treatment in NASH Related Compensated Advanced Chronic Liver Disease.
Recruiting	`NCT04588077` - Comparison Between 2-dose Versus 3-dose Regimens of Heplisav B in Cirrhosis	Phase 4
Recruiting	`NCT04802954` - Risk Stratification of Hepatocarcinogenesis Using a Deep Learning Based Clinical, Biological and Ultrasound Model in High-risk Patients	N/A
Recruiting	`NCT04622449` - Etiopathogenesis of Anemia in Chronic Liver Disease
Enrolling by invitation	`NCT05836246` - The Development of Quantitative Ultrasound Imaging Software Platform
Completed	`NCT03087344` - Postprandial Liver and Spleen Stiffness Measurements in the Noninvasive Diagnosis of Cirrhosis	N/A
Completed	`NCT04751045` - Comparison and Outcomes of Endoscopic Ultrasound Liver Biopsies Versus Percutaneous Liver Biopsies	N/A
Withdrawn	`NCT02899325` - FDGal PET/CT to Detect Hepatocellular Carcinoma
Terminated	`NCT02530567` - Non-invasive Evaluation of Portal Pressure by MRI	N/A
Suspended	`NCT02650011` - Clinical Features and Natural History of Acute-on-Chronic Liver Failure in Korean Patients With Chronic Liver Disease
Completed	`NCT01851252` - MBT Versus HVPG in Identifying Responders to Portal Hypertension Therapy	Phase 1
Terminated	`NCT01756690` - Predicting Lung Injury From Transfusion in Patients With Liver Disease	N/A
Completed	`NCT01600105` - Detection of Liver Fibrosis With Magnetic Resonance Imaging (MRI)	Phase 4
Completed	`NCT01008293` - Effect of Probiotics in Treatment of Minimal Hepatic Encephalopathy (MHE) and Health Related Quality of Life	Phase 2/Phase 3
Completed	`NCT01634698` - Relative-dose-response Test (RDR) Adaptation for Chronic Liver Disease	N/A